Jens Juul Holst

speaker

287 appearances 1 recordings 1 series first heard May 2026 last heard 4 May

Jens Juul Holst’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in May 2026 with 1.

Appearances

newest first · ▶ plays the moment

Discovery · The Life Scientific: Jens Juul Holst · 4 May 2026 podcast

And there are a lot of observations on interactions with GLP-1 with receptors in the immune system.

And there is typically in obesity and diabetes what we call a low-grade inflammation, systemic inflammation.

And this is thought to contribute very much to the problems, the complications.

So that is in the heart.

That is in the liver.

That is in the kidneys.

That is in the lungs.

And that is in the central nervous system.

So one of the theories, and it's actually more than a theory these days because it's quite evident, is that one of the ways GLP-1s improve all these conditions, because they do, is by interfering with the inflammation, reducing the inflammation that causes these problems in the various organs.

So, you know, it's not even miraculous any longer.

It's a fact.

There is a mechanism behind this.

So that's really fantastic, I think.

So first of all, it was predicted.

And it also turns out to be true because what happens when you're in therapy is that you inhibit your appetite.

And because of that, you eat less and then eventually will lose some weight.

But if you regain your appetite, then you will start eating again and you will increase in body weight.

So if you stop the therapy, of course, your body weight will return.

But fortunately, there is something you can do.

Engage in a change of lifestyle.

Showing 221–240 of 287 · page 12 of 15